Navigation Links
Hoag Breast Care Center First in California to Offer 3D Mammography
Date:9/21/2011

econstructed into a series of high-resolution one-millimeter slices that can be reviewed individually or played back in a cine loop.

"Tomosynthesis, by solving the issue of tissue superimposition, will not only allow us to detect breast cancer more reliably, it will also reduce the number of unnecessary call backs for additional testing," adds Dr. Levine. "This will then address a frequent criticism of mammography by reducing anxiety and controlling costs."

A woman can learn if her breasts are dense by asking her physician or the radiologist who performs her mammogram. Breast density is not based on family history and cannot be determined by look and feel of the breast. Approximately 75 percent of women in their forties have dense breasts, and this percentage typically decreases with age – with 54 percent of women in their fifties and 42 percent of women in their sixties having dense breasts.(i) Approximately 40 to 50 percent of women Hoag screens annually have extremely dense breast tissue, particularly younger women ages 40-49.

Regardless of whether a woman has dense breast tissue or not, mammograms and self breast awareness play a crucial role in early detection. Breast cancer is the second leading cause of cancer death among women, exceeded only by lung cancer. Statistics indicate that one in eight women will develop breast cancer sometime in her lifetime. The stage at which breast cancer is detected influences a woman's chance of survival. If found and treated early, while still localized in the breast, the ten-year survival rate for breast cancer is greater than 90 percent.

Hoag is pleased to offer digital breast tomosynthesis to Orange County women due to a generous grant from Circle 1000, a dedicated group of women that have raised funds for Hoag Family Cancer Institute since 1987. In the near future, Hoag will be extending this technology to Irvine as well.

Hoag is committed to the fight against breast cancer. In off
'/>"/>

SOURCE Hoag Memorial Hospital Presbyterian
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 21, 2014 Influenza will affect as many ... the United States as high as ... to spread is from person to person in respiratory droplets ... serve way of death, but kills much fewer people each ... done by human fluids including sweat, saliva, blood and other ...
(Date:10/22/2014)... Va. and AUSTIN, Texas ... Inc. and PureMHC LLC today announced they have ... develop novel antibody-based immunotherapies designed to target cancers. ... of phosphorylated peptides displayed on the surfaces of ... phosphopeptide tumor targets (PTTs), derived from proteins that ...
(Date:10/22/2014)... Mass. and SHANGHAI , ... (NASDAQ: FMI ) and WuXi PharmaTech ... a collaboration to offer Foundation Medicine,s comprehensive genomic profiling ... China . Under the terms ... WuXi to perform the laboratory component of Foundation Medicine,s ...
Breaking Medicine Technology:WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5
... , Event to Highlight Progress in Research, Advocacy and New Treatments , ... WASHINGTON , May 11 The National Organization for ... that have brought innovative new treatments to market for rare diseases at the 2010 NORD ... on Tuesday, May 18 . , , ...
... U.S. Food and Drug Administration recently approved an application that permits B. Braun ... Injection USP and Dextrose Injection USP in B. Braun,s DUPLEX® Drug Delivery System ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ) ... Used in hospitals and healthcare centers ...
Cached Medicine Technology:NORD to Honor Rare Disease Innovators 2NORD to Honor Rare Disease Innovators 3NORD to Honor Rare Disease Innovators 4FDA Approves Cefepime for Use In B. Braun's DUPLEX(R) System 2FDA Approves Cefepime for Use In B. Braun's DUPLEX(R) System 3
(Date:10/22/2014)... (PRWEB) October 22, 2014 Lintelus, Inc., ... Sr. Vice President of Sales, will be speaking on ... Meetings Technology Expo on October 28, at the Holiday ... hosting a booth as well as a Tech Demo ... Meeting can create a more engaging event experience. , ...
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... are only about half as likely as white women to ... indicates, and the racial disparity persists even when donor eggs ... white patients became pregnant after IVF, compared to about 17 ... cycles over two years to tease out the impact of ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter , ... young adult men may lead to increased blood pressure, according ... a similar rise in blood pressure for young adult women ... young adult women drank lightly or moderately, their risk of ... "This finding parallels studies in older adult men and ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Measures taken ... plantation in Ebola-ravaged Liberia may have limited the spread ... researchers report. The Firestone Natural Rubber Co. provides ... and residents of nearby densely populated communities. Between ... and suspected Ebola cases among those 80,000 people. That ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... Blanket Limbo to raise funds for amputees DALLAS, Feb. 18 ... arm or a leg. Of those impacted, many find themselves with ... limbs needed to resume their daily lives. , ... awareness to the plight of these amputees and provide them with ...
... save lives by donating blood regularlySEWELL, N.J., Feb. 18 ... February 21, 2009 from 9:00 a.m. to 3:00 p.m. ... To make an immediate appointment for this blood ... )Koerner is battling a type of cancer called Acute ...
... 18 The ,Help is Here Express, bus tour ... February 23-27 at various cities throughout the state ... information on programs that provide prescription medicines for free ... having risen for seven straight months, standing today at ...
... widely used blood pressure medication may be the key ... according to a newly published study by researchers at ... offer the hope of an improved quality of life ... study drew on a hypothesis from previous studies that ...
... Ill., and Osaka, Japan, February 13, 2009 Takeda ... North America, Inc., announced today that the United States ... 40 mg and 80 mg for the chronic management ... medication is the first new treatment option in more ...
... clinicians and researchers in the bone health field ... held from March 18-21 in Athens, Greece. ... four-day meeting which will feature an expanded scientific ... clinically-oriented ,Meet-the-Professor, sessions. The programme is also enhanced ...
Cached Medicine News:Health News:Limbs for Life Foundation to Host 8th Annual Fundraiser and Live Auction 2Health News:Blood Drive Held in Honor of Sewell, NJ Resident - Ellie Koerner 2Health News:Partnership for Prescription Assistance Prepared to Help Texas Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Texas Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Texas Workers Hurt by Recession 4Health News:Blood pressure compound may benefit brain tumor patients 2Health News:Blood pressure compound may benefit brain tumor patients 3Health News:FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout 2Health News:FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: